International Clinical Trial: A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135973) titled 'A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)' on Aug. 14.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Sanofi

Condition: Chronic Graft Versus Host Disease

Intervention: Drug: Belumosudil

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: August 29, 2025

Target Sample Size: 26

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07135973

Published by HT Dig...